Format

Send to

Choose Destination
Int J Rheumatol. 2018 May 13;2018:5217461. doi: 10.1155/2018/5217461. eCollection 2018.

Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases.

Author information

1
Al Jahra Hospital, Al Jahra, Kuwait.
2
Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
3
Al Amiri Hospital, Kuwait City, Kuwait.
4
Department of Paediatrics, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
5
Mubarak Al-Kabeer Hospital, Jabriya, Kuwait.
6
Al Farwaniya Hospital, Al Farwaniya, Kuwait.
7
Adan Hospital, Hadiya, Kuwait.

Abstract

People with IRD are at increased risk of infection, and in 2011 EULAR made general recommendations for vaccination in these patients. Global and European perspectives are important, but they cannot accurately reflect the individual situations of patients in different countries and regions. Based on our clinical experience and opinions, we have sought to tailor the original EULAR recommendations to include advice for vaccination with new agents approved in the intervening years-including the new class of targeted synthetic disease-modifying antirheumatic drugs. We have also considered the specific demographic needs of patients in local populations in the Gulf region. The resulting 16 recommendations are grouped into four main categories covering general vaccination guidelines and best-practice for all patients with IRD, followed by a set of recommended vaccines against specific pathogens. The last two categories include recommendations for certain patient subgroups with defined risks and for patients who wish to travel.

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center